| Description | Value | Count | Gene symbol |
| GO:0007186 G-protein coupled receptor protein signaling pathway (BP) | 1.25E-07 | 11 | GRM5, LTB4R1, CYSLTR1, TACR3, EDN1, OXTR, PROKR1, GPR143, NMBR, HTR2B, OPN4 | GO:0007166 cell surface receptor linked signal transduction (BP) | 1.97E-06 | 11 | GRM5, LTB4R1, CYSLTR1, TACR3, EDN1, OXTR, PROKR1, GPR143, NMBR, HTR2B, OPN4 | GO:0008528 peptide receptor activity, G-protein coupled (MF) | 6.35E-05 | 4 | TACR3, OXTR, PROKR1, NMBR | GO:0042277 peptide binding (MF) | 1.93E-04 | 4 | TACR3, OXTR, PROKR1, NMBR | GO:0008188 neuropeptide receptor activity (MF) | 3.53E-04 | 3 | TACR3, PROKR1, NMBR | GO:0042165 neurotransmitter binding (MF) | 0.001843 | 3 | TACR3, PROKR1, NMBR | GO:0004974 leukotriene receptor activity (MF) | 0.003007 | 2 | LTB4R1, CYSLTR1 | GO:0003013 circulatory system process (BP) | 0.004138 | 3 | EDN3, EDN1, OXTR | GO:0005886 plasma membrane (CC) | 0.009375 | 8 | GRM5, LTB4R1, CYSLTR1, TACR3, OXTR, PROKR1, NMBR, HTR2B | GO:0042310 vasoconstriction (BP) | 0.011425 | 2 | EDN3, EDN1 | mmu04080: Neuroactive ligand-receptor interaction | 5.51E-08 | 7 | GRM5, LTB4R1, CYSLTR1, TACR3, OXTR, NMBR, HTR2B | mmu04020: Calcium signaling pathway | 3.85E-05 | 5 | GRM5, CYSLTR1, TACR3, OXTR, HTR2B |
|
|